Literature DB >> 1335653

Properties and classification of hepatitis A virus.

J L Melnick1.   

Abstract

Hepatitis A virus (HAV) is a member of the picornavirus family. It was first provisionally classified as enterovirus 72, but subsequent determinations of its nucleotide and amino acid sequences showed them to be sufficiently distinct to assign the virus to a new genus. Heparna-virus (Hep-A-RNA-virus) has been suggested as the genus name. HAV shares the key properties of the picornavirus family: an icosahedral particle 28 nm in diameter with cubic symmetry, composed of 30% RNA and 70% protein. The genome is single-stranded 7.48 kb RNA, linear and positive-sense. Like other picornaviruses, HAV possesses four major polypeptides cleaved from a large precursor polyprotein. The surface proteins VP1 and VP3 are major antibody-binding sites. The internal protein VP4 is much smaller than the VP4s of other picornaviruses. As other picornaviruses, HAV has no envelope and replicates in the cytoplasm. HAV is stable to treatment with either and acid, and is much more heat-resistant than other picornaviruses. It withstands 60 degrees C for 1 h. MgCl2 stabilizes the virus to withstand temperatures up to 80 degrees C. The relative resistance of HAV to disinfection indicates a need for extra precautions in dealing with hepatitis patients and their products. Only one serotype is known. There is no antigenic cross-reactivity with other hepatitis viruses. HAV initially was identified in stool and liver preparations by employing immune electron microscopy as the detection system. Chimpanzees and marmoset monkeys are susceptible to HAV. HAV has been cultivated serially in primary explant cultures of adult marmoset livers and in cell lines of primate origin.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335653     DOI: 10.1016/0264-410x(92)90536-s

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  Detection and characterization of hepatitis A virus and norovirus in mussels from Galicia (NW Spain).

Authors:  Carmen F Manso; Jesús L Romalde
Journal:  Food Environ Virol       Date:  2013-03-08       Impact factor: 2.778

2.  Comparison of concentration methods for detection of hepatitis A virus in water samples.

Authors:  Yuting Qiao; Zhiwei Sui; Guoliang Hu; Huabin Cao; Guoxiang Yang; Yong Li; Yongsong Lei; Lihua Zhao; Quanjiao Chen
Journal:  Virol Sin       Date:  2016-08-10       Impact factor: 4.327

Review 3.  Therapeutic Advances in Viral Hepatitis A-E.

Authors:  Navroop Nagra; Richard A Kozarek; Blaire E Burman
Journal:  Adv Ther       Date:  2022-02-27       Impact factor: 3.845

Review 4.  Safety and effectiveness of the new inactivated hepatitis A virus vaccine.

Authors:  J Furesz; D W Scheifele; L Palkonyay
Journal:  CMAJ       Date:  1995-02-01       Impact factor: 8.262

5.  Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020.

Authors:  Noele P Nelson; Mark K Weng; Megan G Hofmeister; Kelly L Moore; Mona Doshani; Saleem Kamili; Alaya Koneru; Penina Haber; Liesl Hagan; José R Romero; Sarah Schillie; Aaron M Harris
Journal:  MMWR Recomm Rep       Date:  2020-07-03

6.  Full-length genomic sequence of subgenotype IIIA hepatitis A virus isolate in Republic of Korea.

Authors:  Ah-Ra Lee; Sung-Geun Lee; Lae-Hyung Kang; Weon-Hwa Jheong; Soon-Young Paik
Journal:  Biomed Res Int       Date:  2013-08-07       Impact factor: 3.411

Review 7.  Current status and strategies for the control of viral hepatitis A in Korea.

Authors:  Eileen L Yoon; Dong Hyun Sinn; Hyun Woong Lee; Ji Hoon Kim
Journal:  Clin Mol Hepatol       Date:  2017-09-19

8.  Genotypes of hepatitis a virus in Turkey: first report and clinical profile of children infected with sub-genotypes IA and IIIA.

Authors:  Huseyin Yilmaz; Asiye Karakullukcu; Nuri Turan; Utku Y Cizmecigil; Aysun Yilmaz; Ayse A Ozkul; Ozge Aydin; Alper Gunduz; Mahmut Mete; Fadile Y Zeyrek; Taner T Kirazoglu; Juergen A Richt; Bekir Kocazeybek
Journal:  BMC Infect Dis       Date:  2017-08-11       Impact factor: 3.090

9.  Study of the biological activity of novel synthetic compounds with antiviral properties against human rhinoviruses.

Authors:  Samuela Laconi; Maria A Madeddu; Raffaello Pompei
Journal:  Molecules       Date:  2011-04-26       Impact factor: 4.411

10.  Molecular epidemiology of hepatitis A virus in the South-East area of Gyeonggi-do in Korea.

Authors:  Han Ul Song; Seong Gyu Hwang; Chang-Il Kwon; Ji Eun Lee; Kwang Hyun Ko; Sung Pyo Hong; Phil Won Park; Kyu Sung Rim
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.